Oncogene Fusion

Download PDF

Recent Publications on Oncogene Fusion:
ETV6-NCOA2: a novel fusion gene in acute leukemia associated with coexpression of T-lymphoid and myeloid markers and frequent NOTCH1 mutations. PURPOSE: The ETV6 gene has been reported to be fused to a multitude of...	5th June, 2008	Children's Cancer Research Institute, St. Anna Kinderkrebsforschung,	Clin Cancer Res. 2008 Feb 15;14(4):977-83. DOI Direct Link
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia. Recurrent gene fusions involving oncogenic ETS transcription factors...	28th March, 2008		Leukemia. 2008 Mar;22(3):663-5. Epub 2007 Sep 6. DOI Direct Link
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Recurrent gene fusions involving oncogenic ETS transcription factors...	20th February, 2008	Michigan Center for Translational Pathology, Department of Pathology,	Cancer Res. 2008 Jan 1;68(1):73-80. DOI Direct Link
The CALM-AF10 fusion is a rare event in acute megakaryoblastic leukemia. The recent description of a new X chromosome tumor suppressor gene, WTX,...	28th December, 2007		Leukemia. 2007 Dec;21(12):2568-9. Epub 2007 Jul 5. DOI Direct Link
[TMPRSS2-ETS gene fusion in prostate cancer] BACKGROUND: Recurrent chromosomal rearrangements have not been well...	14th December, 2007	Department of Pathology, Brigham & Women's Hospital/Harvard Medical	Urologe A. 2007 Jul;46(7):754-60. DOI Direct Link
→View more research publications.

BioNews Results for Oncogene Fusion:
Akt compositions for enhancing survival of cells	PharmCast:  May 22 2008 3:53AM Matching: oncogene fusion

Oncogene Fusion Patents:
US Patent No.	Title
7255862	ALVAC/FIV constructs
6380171	Pro-protein converting enzyme
6329179	Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer
6281329	Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
6224882	Insect cells or fractions as adjuvant for antigens
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Oncogene Fusion scientists - we have details of around 3 individuals working on Oncogene Fusion .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.